Co-reactive | $7,754,157 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
EpiBiologics
United States
- San Mateo, California
- 09/01/2026
- Series B
- $107,000,000
EpiBiologics is advancing bispecific antibodies that selectively degrade membrane and soluble proteins, including GPCRs. Our EpiTAC platform leverages a novel atlas of tissue-selective degrader receptors to drive deep and durable efficacy. The company was founded in 2022 based on pioneering work from Dr. Jim Wells at UCSF. Headquartered in the SF Bay Area, EpiBiologics is backed by leading healthcare investors and building a clinical stage pipeline for oncology and immunology. For more information, please visit epibiologics.com and follow us on LinkedIn.
- Industry Biotechnology Research
- Website https://www.epibiologics.com/
- LinkedIn https://www.linkedin.com/company/epibiologics-inc/
Related People
Ann Lee-KarlonFounder
United States -
San Francisco Bay Area
CEO of EpiBiologics, former COO of Altos Labs, and former SVP at Genentech.
EpiBiologics is advancing bispecific antibody protein degradation therapeutics with a wide range of applications, including oncology and immunology.
Former COO at Altos and employee #2. Instrumental in scaling company to 500 employees over 3 global sites.
Former SVP at Genentech. Portfolio strategy and project leadership oversight for >80 drug development teams over 18 years from research and early development through FDA and global approvals and launch. Led Ocrevus team for multiple sclerosis and Rituxan in immunology. Led major corporate partnerships.
President and Board Chair of Genentech Patient Foundation (2016-2019), providing medicines to uninsured and underinsured patients.
Board member of Dean’s engineering advisory boards for UC Berkeley and UCSD. Commencement speaker for UC Berkeley Engineering PhD 2022 graduation ceremony.
Honored by the UC Office of the President as one of the Remarkable Women of the University of California. President and Board Chair of the Association for Women in Science in Washington, D.C.
Fellow of the Aspen Institute. Fellow of the American Institute for Medical and Biological Engineering.
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)
Gyde | $60,000,000 | (Jan 29, 2026)